A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals

被引:439
作者
Martinez, MN
Amidon, GL
机构
[1] US FDA, Ctr Vet Med, Off New Anim Drug Evaluat, Rockville, MD 20855 USA
[2] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
关键词
D O I
10.1177/00970002042006005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article provides an overview of the patient-specific and drug-specific variables that can affect drug absorption following oral product administration. The oral absorption of any chemical entity reflects a complex spectrum of events. Factors influencing product bioavailability include drug solubility, permeability, and the rate of in vivo dissolution. In this regard, the Biopharmaceutics Classification System has proven to be an important tool for predicting compounds likely to be associated with bioavailability problems. It also helps in identifying those factors that may alter the rate and extent of drug absorption. Product bioavailability can also be markedly influenced by patient attributes such as the integrity of the gastrointestinal tract, physiological status, site of drug absorption. membrane transporters, presystemic drug metabolism (intrinsic variables), and extrinsic variables such as the effect of food or concomitant medication. Through an awareness of a drug's physicochemical properties and the physiological processes affecting drug absorption. the skilled pharmaceutical scientist can develop formulations that will maximize product availability. By appreciating the potential impact of patient physiological status, phenotype, age, gender, and lifestyle, dosing regimens can be tailored to better meet the needs of the individual patient. (C) 2002 the American College of Clinical Pharmacology.
引用
收藏
页码:620 / 643
页数:24
相关论文
共 150 条
[1]  
Abdou H., 1989, DISSOLUTION BIOAVAIL
[2]   THE EFFECT OF MANNITOL ON THE ORAL BIOAVAILABILITY OF CIMETIDINE [J].
ADKIN, DA ;
DAVIS, SS ;
SPARROW, RA ;
HUCKLE, PD ;
WILDING, IR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (12) :1405-1409
[3]   STUDIES ON THE ROLE OF INTESTINAL BACTERIA IN METABOLISM OF SYNTHETIC AND NATURAL STEROID-HORMONES [J].
ADLERCREUTZ, H ;
PULKKINEN, MO ;
HAMALAINEN, EK ;
KORPELA, JT .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (01) :217-229
[4]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[5]   Predicting human oral bioavailability of a compound: Development of a novel quantitative structure-bioavailability relationship [J].
Andrews, CW ;
Bennett, L ;
Yu, LX .
PHARMACEUTICAL RESEARCH, 2000, 17 (06) :639-644
[6]   Drug exsorption from blood into the gastrointestinal tract [J].
Arimori, K ;
Nakano, M .
PHARMACEUTICAL RESEARCH, 1998, 15 (03) :371-376
[7]   Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist [J].
Aungst, BJ ;
Saitoh, H .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :114-119
[8]   Role of transport proteins in drug absorption, distribution and excretion [J].
Ayrton, A ;
Morgan, P .
XENOBIOTICA, 2001, 31 (8-9) :469-497
[9]   Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery [J].
Benet, LZ ;
Izumi, T ;
Zhang, YC ;
Silverman, JA ;
Wacher, VJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) :25-31
[10]   The drug efflux-metabolism alliance: biochemical aspects [J].
Benet, LZ ;
Cummins, CL .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S3-S11